You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Medtronic
Merck
AstraZeneca
Boehringer Ingelheim
Colorcon
Mallinckrodt

Last Updated: January 28, 2021

DrugPatentWatch Database Preview

Drugs in Development Information for Levonordefrin

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the development status for investigational drug Levonordefrin?

Levonordefrin is an investigational drug.

There have been 5 clinical trials for Levonordefrin. The most recent clinical trial was a Phase 2 trial, which was initiated on October 1st 2020.

The most common disease conditions in clinical trials are Pulpitis, Trismus, and [disabled in preview]. The leading clinical trial sponsors are Cairo University, University of Sao Paulo, and Novalar Pharmaceuticals, Inc.

There are one hundred and fifty US patents protecting this investigational drug and one international patent.

Recent Clinical Trials for Levonordefrin
TitleSponsorPhase
Effect of TheraCal Pulpotomy (PT) Pulpotomy Versus MTA Pulpotomy on the Survival Rate of Vital Primary MolarsCairo UniversityN/A
Effect of Magnesium Sulphate Added to Mepivacaine Hydrochloride on Inferior Alveolar Nerve Block Success in Patients With Symptomatic Irreversible Pulpitis in Mandibular Molars: A Randomized Clinical Trial.Cairo UniversityN/A
Anesthetic Efficacy of %4Alexadricaine Versus %2 Mepicaine-L in ChildrenCairo UniversityPhase 3

See all Levonordefrin clinical trials

Clinical Trial Summary for Levonordefrin

Top disease conditions for Levonordefrin
Top clinical trial sponsors for Levonordefrin

See all Levonordefrin clinical trials

US Patents for Levonordefrin

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Levonordefrin   Start Trial Methods and compositions for treating infection UNIVERSITY OF ROCHESTER (Rochester, NY) UNIVERSITY OF KANSAS (Lawrence, KS)   Start Trial
Levonordefrin   Start Trial Treatment of sexual dysfunction Rejoy (Irvine, CA)   Start Trial
Levonordefrin   Start Trial Small molecule agonists of neurotensin receptor 1 SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE (La Jolla, CA)   Start Trial
Levonordefrin   Start Trial Cross-linked collagen comprising metallic anticancer agents MiMedx Group, Inc. (Marietta, GA)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Levonordefrin

Drugname Country Document Number Estimated Expiration Related US Patent
Levonordefrin World Intellectual Property Organization (WIPO) WO2014052836 2032-09-27   Start Trial
Levonordefrin European Patent Office EP3307280 2035-06-11   Start Trial
Levonordefrin World Intellectual Property Organization (WIPO) WO2016201286 2035-06-11   Start Trial
Levonordefrin Canada CA2952732 2034-06-25   Start Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Merck
AstraZeneca
Boehringer Ingelheim
Colorcon
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.